Skip to main content
. 2014 Feb 21;20(7):1822–1832. doi: 10.3748/wjg.v20.i7.1822

Table 2.

Effect of sophocarpine on the improvement in serum alanine aminotransferase, aspartate aminotransferase and total bilirubin levels in both models of liver fibrosis

Group ALT (U/L) AST (U/L) TB (mmol/L)
Normal 29.29 ± 1.76 123.67 ± 29.06 1.29 ± 0.28
DMN model 68.27 ± 3.43 176.9 ± 8.99 8.09 ± 1.35
DMN + sophocarpine 48.58 ± 4.521 108.42 ± 15.461 3.00 ± 0.481
Sham operation 28.83 ± 2.22 121.00 ± 36.72 2.00 ± 0.63
BDL model 150.50 ± 23.6 959.50 ± 255 139.67 ± 16.23
BDL + sophocarpine 91.86 ± 6.711 464.14 ± 182.61 123.86 ± 9.69
1

Compared with the model group, P < 0.05. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TB: Total bilirubin; DMN: Dimethylnitrosamine; BDL: Bile duct ligation.